Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kletting

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Zeitschrift Fur Medizinische Physik|September 19, 2009
Model selection for time-activity curves: the corrected Akaike information criterion and the F-testPeter Kletting, Gerhard Glatting
Zeitschrift Fur Medizinische Physik|May 3, 2011
Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: a simulation studyPeter Kletting, Sven N Reske, Gerhard Glatting
Nuklearmedizin. Nuclear Medicine|March 27, 2009
Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistributionFranz Kiraly, Peter Kletting, Sven Reske, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: an investigation based on pharmacokinetic modelingPeter Kletting, Christoph Meyer, Sven N Reske, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic modelPeter Kletting, Donald Bunjes, Sven N Reske, et al.
Physics in Medicine and Biology|December 2, 2010
Analysing saturable antibody binding based on serum data and pharmacokinetic modellingPeter Kletting, Hady Kiryakos, Sven N Reske, et al.
Physics in Medicine and Biology|October 13, 2009
Comparing time activity curves using the Akaike information criterionPeter Kletting, Thomas Kull, Sven N Reske, et al.
EJNMMI Physics|June 20, 2020
Influence of sampling schedules on [<sup>177</sup>Lu]Lu-PSMA dosimetryAndreas Rinscheid, Peter Kletting, Matthias Eiber, et al.
Medical Physics|December 13, 2007
Choosing the optimal fit function: comparison of the Akaike information criterion and the F-testGerhard Glatting, Peter Kletting, Sven N Reske, et al.
Plos One|May 27, 2015
Physiologically Based Pharmacokinetic Modeling Is Essential in 90Y-Labeled Anti-CD66 RadioimmunotherapyPeter Kletting, Christian Maaß, Sven Reske, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Zeitschrift Fur Medizinische Physik|September 19, 2009
Model selection for time-activity curves: the corrected Akaike information criterion and the F-testPeter Kletting, Gerhard Glatting
Zeitschrift Fur Medizinische Physik|May 3, 2011
Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: a simulation studyPeter Kletting, Sven N Reske, Gerhard Glatting
Nuklearmedizin. Nuclear Medicine|March 27, 2009
Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistributionFranz Kiraly, Peter Kletting, Sven Reske, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 29, 2010
Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: an investigation based on pharmacokinetic modelingPeter Kletting, Christoph Meyer, Sven N Reske, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic modelPeter Kletting, Donald Bunjes, Sven N Reske, et al.
Physics in Medicine and Biology|December 2, 2010
Analysing saturable antibody binding based on serum data and pharmacokinetic modellingPeter Kletting, Hady Kiryakos, Sven N Reske, et al.
Physics in Medicine and Biology|October 13, 2009
Comparing time activity curves using the Akaike information criterionPeter Kletting, Thomas Kull, Sven N Reske, et al.
EJNMMI Physics|June 20, 2020
Influence of sampling schedules on [<sup>177</sup>Lu]Lu-PSMA dosimetryAndreas Rinscheid, Peter Kletting, Matthias Eiber, et al.
Medical Physics|December 13, 2007
Choosing the optimal fit function: comparison of the Akaike information criterion and the F-testGerhard Glatting, Peter Kletting, Sven N Reske, et al.
Plos One|May 27, 2015
Physiologically Based Pharmacokinetic Modeling Is Essential in 90Y-Labeled Anti-CD66 RadioimmunotherapyPeter Kletting, Christian Maaß, Sven Reske, et al.
Pageof 5